CWRU Technology Ventures
Funding platformCleveland Β· Pre-SeedβSeed Β· 1 people tracked
Investment thesis
Technology commercialization arm of Case Western Reserve University that supports and spins out startups based on university research.
Source: firm website, verified Aug 3, 2026.
Team Β· 1 people
from public directoriesWhat they invest in
from 30 of 40 portfolio companiesHealthtech Γ20Biotech Γ18Medical Devices Γ18Deep Tech Γ8Digital Health Γ6AI & Machine Learning Γ4Data & Infrastructure Γ3Cleantech Γ2
HQs:United StatesΓ21MexicoΓ1
Who they back
founder profiles across 13 portfolio companiesFounding team size:solo founderΓ52 foundersΓ43 foundersΓ4
Investments Β· 40 tracked
founders shown can be your intro pathBy year:2022 Β· 22017 Β· 13 dated
Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer.
BiotechDigital HealthHealthtechMedical DevicesLake Forest, US
Michael A Gordon(Executive Officer)Shaun O'Neil(Executive Officer)inLishan Aklog(Chairman & CEO)inDennis McGrath(Executive Officer)inBrian deGuzman(Chief Technology Officer & Chief Compliance Officer)in
BoardDENNIS A. MATHEIS(Director)
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.
BiotechDeep TechHealthtechMedical Devices
Dr. Jerry SilverHarold Punnett(Co-founder)inJerry Silver(Co-founder)William Adams(Executive Officer)Paul Brennan(Director, Executive Officer)Daniel Mikol(Executive Officer)
Co-investorsSCI Ventures
Afference develops neurotechnology that enables remote sensory perception through wearable devices, allowing people at a distance to share tactile sensations.
AI & Machine LearningDeep TechHardwareHealthtechCleveland, US
Jacob Segil(Co-founder & CEO)inDustin Tyler(Co-founder & CTO)in
BoardTaylor Hurst(Director)inTrevor Zimmerman(Director)in
Co-investorsAnthropy PartnersEvolution VC PartnersHannah Grey VenturesJobsOhio VenturesKonvoy VenturesMighty Capital+5 more
AlensiaXR develops holographic technology that replaces traditional cadavers in medical and dental education.
Deep TechEdTechHealthtech
Mark Day(Chief Executive Officer)in
Co-investorsJobsOhio VenturesJumpstart Ventures
Atelerix Life Sciences develops novel respiratory therapies for drug-induced respiratory depression, respiratory disease exacerbations, and bio-defense against respiratory threats.
BiotechHealthtechMedical DevicesIndianapolis, US
David Kalergis(Executive Officer, Director, Promoter)William Akridge(Director)
BoardPeter Barton Hutt(Director)
BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods.
BiotechHealthtechMedical DevicesCleveland, US
BIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations.
Digital HealthDirect to ConsumerWellness & FitnessCleveland, US
Mahmoud Ghannoum(Founder)Afif Ghannoum(Director)Sam Schatz(Executive Officer)Michael Haritakis(Executive Officer)Steven Himmel(Director)
BoardBob Pavey(Director)
Co-investorsJobsOhio VenturesJumpstart VenturesMiddleland Capital
Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses.
BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US
George B. Rathmann(First CEO)
BoardWilliam K. Bowes
Co-investorsAsset Management CompanyBOMMayfield FundUS Venture PartnersYsios Capital
Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders.
BiotechHealthtech
BONEZONE is a media platform and conference brand serving orthopedic device manufacturers with editorial content, digital publications, and industry networking focused on product development, regulatory trends, and market intelligence.
Marketing TechMedia & EntertainmentMedical Devices
Convelo Therapeutics develops remyelination-enhancing therapies that target the central nervous system's myelination pathway to repair nerve damage in people with multiple sclerosis.
BiotechDeep TechHealthtechCleveland, US
Paul Tesar(Co-founder (Professor, PhD))inDrew Adams(Co-founder (Professor, PhD))Derrick Rossi(Leader/Executive)Tracy Saxton(Chief Operating Officer)Ed Mok(Head of Finance)Samantha Stubblefield(VP of Operations and Business Development)
Co-investorsJobsOhio VenturesJumpstart Ventures
COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease.
BiotechDeep TechHealthtechMedical DevicesCleveland, US
Edifice Analytics provides software that quantifies energy and cost savings opportunities in commercial buildings using diagnostics, prognostics, and comparative analytics.
CleantechData & InfrastructureEnterprise SoftwareCleveland, US
Alexis Abramson(Co-founder / Senior Technical Advisor)Roger French(Co-founder / CTO)Dave Gordon(CEO)
Medtronic designs and develops medical technology for treating complex diseases.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investors8VCElevate VenturesMenlo VenturesOak Investment PartnersPfizer Venture InvestmentsQuesta Capital+5 more
Folio Photonics develops optical storage media using multi-layer read/write materials science to provide enterprise-scale, immutable active archive storage.
Data & InfrastructureDeep TechNew MaterialsSolon, US
Kenneth D. Singer(Executive Officer, Director)Steven J. Santamaria(Executive Officer, Director)Ronald B. Richard(Director)Robert D. Pavey(Director)Felix Brueck(Director)
Co-investorsJobsOhio VenturesMaterial ImpactRefinery VentureForte Ventures
Global Health Metrics provides population health analytics and risk assessment tools for health plans, employers, and healthcare providers.
Data & InfrastructureEnterprise SoftwareHealthtech
Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders.
BiotechMedical Devices
Anirban Sen Gupta(CTO)Michael Bruckman(CEO)Matthew Neal(CMO)Christa Pawlowski(COO and EVP of R&D)Timothy Pelura(Executive Chair)
Co-investorsTachyon Ventures
Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants.
Digital HealthHealthtechMedical DevicesPortland, US
Patricia White Seminario(Executive Officer, Director, Promoter)Peter Galen(Chief Innovation Officer, Co-Founder)Patti White(Chief Executive Officer, Co-Founder)Daren Bledsoe(Sr. VP, Engineering & Operations)inGerrit van Roekel(VP, Business Development)inUmut Gurkan(Chief Scientist, Microfluidics)in
Co-investorsPortland Seed FundElevate Capital
Light-Handed is developing diagnostic technology to improve the diagnosis of middle ear effusion (MEE), applying biomedical optics to medical device development.
Deep TechHardwareHealthtechMedical Devices
Steven Burns(Chief Executive Officer)inBrecken Blackburn(Chief Science Officer)inMatt McPheeters(Chief Technology Officer)in
Co-investorsJumpStart Equity
BiotechHealthtechMedical DevicesMinneapolis, US
David Largaespada(Executive Officer, Director, Promoter)Jeff Liter(Executive Officer, Director, Promoter)James Haymaker(Director, Promoter)
BoardJeff Ross(Director)John Wells(Director)Tracey Lodie(Director)
MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound.
BiotechHealthtechMedical DevicesOhio, US
Audrey Carballo
Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
BiotechHealthtechMedical DevicesWellington, US
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)
BoardJoyce Erony(Director)inWilliam Harrington(Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+5 more
Picture Health develops AI tools that analyze routine radiology and pathology images to quantify biological properties of tumors for precision oncology.
AI & Machine LearningBiotechHealthtech
Co-investorsCintrifuse CapitalJobsOhio VenturesRefinery Venture
Cleveland-based polymeric development company acquired by Peak Nanosystems for $25M in 2020.
BiotechSeattle, US
Sanford Markowitz(Director)Thong Le(Executive Officer, Director, Promoter)David Schubert(Executive Officer, Promoter)James Sullivan(Director)Lindsay Rayle(Executive Officer, Promoter)Tadataka Yamada(Director)
Co-investorsVentac Partners
Developing an HIV vaccine to allow patients treatment-free latency periods of 12-24 months.
Symphony Robotics develops investigational robotic technology for healthcare applications.
Medical DevicesRobotics
Synapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS.
BiotechDigital HealthHealthtechMedical DevicesHarrisburg, US
Anthony R Ignagni(Executive Officer, Director)Raymond P Onders(Director)Anthony R. Ignagni(Co-founder, President & CEO)Moustapha Diop(Chief Operating Officer)Kiyotaka Mori(Director)John Krystowski(Director)
Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy.
BiotechBoston, US
Harvey LodishDaniel FischerWarren Lammert
Co-investorsGood Growth CapitalLauder Partners
Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research.
AI & Machine LearningBiotechDeep TechMedical DevicesBeachwood, US
Jan Jensen(Founder)inJoshua Snow(Chief Commercial Officer)Divya Trivedi(Chief Operating Officer and Secretary)David Llewellyn(President & CEO)Josh Snow(Chief Commercial Officer)inJennifer Antonchuk(Vice President of Research and Development)in
Exits Β· 3
IPOs and acquisitions across the tracked portfolioLucid DiagnosticsNASDAQ: LUCDNervGen PharmaNASDAQ: NGENPolymerPlusacq. by Peaknano
Portfolio news
latest coverage across their companiesLuminary Therapeutics Β· alacrita.com Β· Feb 9, 2026
Neuros Medical Β· finance.yahoo.com Β· Jul 10, 2025
Alensia XR Β· healthysimulation.com Β· May 1, 2025
Frequently asked questions
- How many investments has CWRU Technology Ventures made?
- CWRU Technology Ventures has 40 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does CWRU Technology Ventures invest at?
- CWRU Technology Ventures invests at the Pre-Seed, Seed stages.
- What is CWRU Technology Ventures's typical check size?
- CWRU Technology Ventures typically writes checks of $50K β $250K.
- What sectors does CWRU Technology Ventures focus on?
- CWRU Technology Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is CWRU Technology Ventures located?
- CWRU Technology Ventures is headquartered in Cleveland, US.
- Who does CWRU Technology Ventures co-invest with?
- CWRU Technology Ventures most often shares deals with JobsOhio Ventures, Jumpstart Ventures, Refinery Venture, among 41 tracked co-investors.
Images
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.






.jpeg)
